Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation. Hernando-Requejo O, López M, Cubillo A, Rodriguez A, Ciervide R, Valero J, Sánchez E, Garcia-Aranda M, Rodriguez J, Potdevin G, Rubio C. Strahlenther Onkol. 2014 Jun;190(6):515-20. doi: 10.1007/s00066-014-0650-0. Epub 2014 Apr 9.

Phase II Trial of Target-guided Personalized Chemotherapy in First-line Metastatic Colorectal Cancer. Cubillo A, Rodriguez-Pascual J, López-Ríos F, Plaza C, García E, Alvarez R, de Vicente E, Quijano Y, Hernando O, Rubio C, Perea S, Sanchez G, Hidalgo M. Am J Clin Oncol. 2014 Feb 10. [Epub ahead of print]

A preclinical and clinical study of mycophenolate mofetil in Pancreatic cancer. Rodríguez-Pascual J, Sha P, García-García E, Rajeshkumar NV, De Vicente E, Quijano Y, Cubillo A, Angulo B, Hernando O, Hidalgo M. Invest New Drugs. 2013 Feb;31(1):14-9. doi: 10.1007/s10637-012-9822-x.

Extracranial stereotactic body radiotherapy. Review of main SBRT features and indications in primary tumors. Rubio C, Morera R, Hernando O, Leroy T, Lartigau SE. Rep Pract Oncol Radiother. 2013 Nov 1;18(6):387-96. doi: 10.1016/j.rpor.2013.09.009. Review.

In response to ESTRO 2012 strategy meeting: vision for Radiation Oncology (published April 2012). Macià M, Rubio C, Romero J, Hervas A; Spanish Society of Radiation Oncology (SEOR), Vera A, Britton R, Zunino S, Solé J, de la Torre M, Fernández A; Latin American Association of Radiation Oncology (ALATRO), Trigo L, Rodrigues R, Salgado ML; Portuguese Society of Radiation Oncology (SPRO). Radiother Oncol. 2013 Oct;109(1):181-2. doi: 10.1016/j.radonc.2013.08.042. Epub 2013 Sep 20.

A prospective pilot study of target-guided personalized chemotherapy with intensity-modulated radiotherapy in patients with early rectal cancer. Cubillo A, Hernando-Requejo O, García-García E, Rodriguez-Pascual J, De Vicente E, Morelli P, Rubio C, López-Ríos F, Muro A, López U, Prados S, Quijano Y, Hidalgo M. Am J Clin Oncol. 2014 Apr;37(2):117-21. doi: 10.1097/COC.0b013e31826e0703.

[Treatment of lung lesions by stereotactic body radiation therapy after computed tomography guided placement of a Visicoil(®) marker: initial experience]. Fernández-Velilla Peña M, Rubio Rodríguez C, Allona Krauel M, Hernando Requejo O, Sánchez Saugar E, Muro de la Fuente A, Torres Sánchez MI. Radiologia. 2013 May-Jun;55(3):225-32. doi: 10.1016/j.rx.2011.09.020. Epub 2012 Jan 9. Spanish.

Multidisciplinary approach of colorectal liver metastases. Juez I, Rubio C, Figueras J. Clin Transl Oncol. 2011 Oct;13(10):721-7. doi: 10.1007/s12094-011-0722-x. Review.

The white book of radiation oncology in Spain. Herruzo I, Romero J, Palacios A, Mañas A, Samper P, Bayo E, Guedea F; Libro Blanco de Oncología Radioterápica. Clin Transl Oncol. 2011 Jun;13(6):385-95.

Current perspectives of treatment of ductal carcinoma in situ. Estévez LG, Alvarez I, Seguí MÁ, Muñoz M, Margelí M, Miró C, Rubio C, Lluch A, Tusquets I. Cancer Treat Rev. 2010 Nov;36(7):507-17. doi: 10.1016/j.ctrv.2010.03.007. Epub 2010 May 11. Review.

Clinical application of fluorocholine positron emission tomography in relapsed prostate cancer. Oelstrom M, Núñez R, Sanchez P, Sanchez-Saugar E, Garcia-Cañamaque L, Duran I. Actas Urol Esp. 2012 Jul-Aug;36(7):444-6. doi:10.1016/j.acuro.2011.11.018

Consensus on the treatment of pancreatic cancer in Spain. Hidalgo M, Abad A, Aranda E, Díez L, Feliu J, Gómez C, Irigoyen A, López R, Rivera F, Rubio C, Sastre J, Tabernero J, Díaz-Rubio E. Clin Transl Oncol. 2009 May;11(5):290-301. Review.

Impact of neoadjuvant hormonal therapy on dose-volume histograms in patients with localized prostate cancer under radical radiation therapy. Samper PM, López Carrizosa MC, Pérez Casas A, Vallejo C, Rubio Rodríguez MC, Pérez Vara C, Melchor Iñiguez M. Clin Transl Oncol. 2006 Aug;8(8):599-605.

Institutional experience on the treatment of lung and liver lesions with stereotactic body radiotherapy with Novalis Exactrac Adaptive Gating Technique. Ovidio Hernando, Emilio Sánchez, Pedro Fernández Letón, Daniel Zucca, JM Pérez Moerno, Mariola García Aranda, Jeannette Valero, Mercedes López, Raquel Ciérvide, Carmen Rubio. Clinical Investigation. Journal of Radiosurgery and SBRT, Vol 0: 1-6, 2011.

Tratamiento de lesiones pulmonares mediante radioterapia estereotáxica extracraneal tras colocación guiada por tomografía computarizada de marcador visicoil. Experiencia inicial. M Fernández- Velilla, Carmen Rubio, M Allona, O. Hernando, E Sanchez, T Muro y M Torres. Radiología 2012

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Biete Sola A, Kirova YM, Pignol JP, Remouchamps V, Verhoeven K, Weltens C, Arenas M, Gabrys D, Kopek N, Krause M, Lundstedt D, Marinko T, Montero A, Yarnold J, Poortmans P.Radiother Oncol. 2015 Jan;114(1):3-10. doi:10.1016/j.radonc.2014.11.030.

Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy. Ciervide R, Dhage S, Guth A, Shapiro RL, Axelrod DM, Roses DF, Formenti SC. Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e159-64

Why is partial-breast irradiation still investigational. Ciérvide R, Formenti SC. Am J Clin Oncol. 2012 Jun;35(3):290-2

Comparison of Acute and Late Toxicity of Two Regimens of 3- and 5-Week Concomitant Boost Prone IMRT to Standard 6-Week Breast Radiotherapy. Raza S, Lymberis SC, Ciervide R, Axelrod D, Fenton-Kerimian M, Magnolfi C, Rosenstein B, Dewyngaert JK, Formenti SC. Front Oncol. 2012 May 8;2:44.

To Top